These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2375141)
21. Hypocalcaemia after an occult calcium channel blocker overdose: a case report and literature review. Price D; Radke J; Albertson T Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):217-21. PubMed ID: 24034162 [TBL] [Abstract][Full Text] [Related]
23. Verapamil overdose: case report and review of the literature. Watling SM; Crain JL; Edwards TD; Stiller RA Ann Pharmacother; 1992 Nov; 26(11):1373-8. PubMed ID: 1477440 [TBL] [Abstract][Full Text] [Related]
24. Long-term safety and efficacy comparison of immediate-release and sustained-release oral verapamil in systemic hypertension. Frishman WH; Eisen G; Charlap S; Strom JA J Clin Hypertens; 1987 Dec; 3(4):605-9. PubMed ID: 3134517 [TBL] [Abstract][Full Text] [Related]
26. A case of severe verapamil overdose. Oe H; Taniura T; Ohgitani N Jpn Circ J; 1998 Jan; 62(1):72-6. PubMed ID: 9559422 [TBL] [Abstract][Full Text] [Related]
27. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium. Buckley N; Dawson AH; Howarth D; Whyte IM Med J Aust; 1993 Feb; 158(3):202-4. PubMed ID: 8450791 [TBL] [Abstract][Full Text] [Related]
28. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center. Levine M; Curry SC; Padilla-Jones A; Ruha AM Ann Emerg Med; 2013 Sep; 62(3):252-8. PubMed ID: 23642908 [TBL] [Abstract][Full Text] [Related]
29. Massive ingestion of sustained-release verapamil with a concretion and bowel infarction. Sporer KA; Manning JJ Ann Emerg Med; 1993 Mar; 22(3):603-5. PubMed ID: 8442554 [TBL] [Abstract][Full Text] [Related]
30. Acute asthma associated with sustained-release verapamil. Ben-Noun L Ann Pharmacother; 1997 May; 31(5):593-5. PubMed ID: 9161656 [TBL] [Abstract][Full Text] [Related]
31. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension. Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798 [TBL] [Abstract][Full Text] [Related]
32. [The toxicity of slow-release verapamil and chronic kidney disease]. Huelmos A; Alegría E; Vázquez C Rev Esp Cardiol; 1994 Nov; 47(11):780. PubMed ID: 7800911 [No Abstract] [Full Text] [Related]
33. A new sustained-release formulation of verapamil in the treatment of hypertension. Midtbo KA; Hals O; Lauve O J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222 [TBL] [Abstract][Full Text] [Related]
37. [Poisoning by delayed-release verapamil in an uremic patient]. Robles NR; García Díaz MC; Fernández Mora G; Sánchez Casado E Med Clin (Barc); 1992 Dec; 99(19):741-2. PubMed ID: 1460941 [TBL] [Abstract][Full Text] [Related]
38. Serum verapamil concentrations before and after Intralipid® therapy during treatment of an overdose. French D; Armenian P; Ruan W; Wong A; Drasner K; Olson KR; Wu AH Clin Toxicol (Phila); 2011 Apr; 49(4):340-4. PubMed ID: 21563913 [TBL] [Abstract][Full Text] [Related]
40. Verapamil toxicity: an unusual case report and review of the literature. Batalis NI; Harley RA; Schandl CA Am J Forensic Med Pathol; 2007 Jun; 28(2):137-40. PubMed ID: 17525564 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]